Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-329963
Filing Date
2025-12-23
Accepted
2025-12-23 09:52:27
Documents
6
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 6-K d937172d6k.htm 6-K 8971
2 EX-99.1 d937172dex991.htm EX-99.1 17130
3 EX-99.2 d937172dex992.htm EX-99.2 27598
4 GRAPHIC g937172footer.jpg GRAPHIC 2731
5 GRAPHIC g937172g1223102003516.jpg GRAPHIC 2601
6 GRAPHIC g937172g1223172236039.jpg GRAPHIC 2601
  Complete submission text file 0001193125-25-329963.txt   66292
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251595692
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)